Anshan Hifichem Co., Ltd.
300758.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.63 | 16.99 | -2.11 |
| FCF Yield | 1.19% | -4.41% | -2.08% | -0.01% |
| EV / EBITDA | 15.53 | 20.55 | 31.61 | 17.32 |
| Quality | ||||
| ROIC | 4.38% | 0.44% | -0.09% | 8.44% |
| Gross Margin | 33.88% | 25.25% | 26.17% | 31.61% |
| Cash Conversion Ratio | 1.01 | 0.16 | 8.15 | 0.80 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.07% | -3.30% | 6.22% | 24.70% |
| Free Cash Flow Growth | 135.20% | -64.53% | -15,772.44% | 99.55% |
| Safety | ||||
| Net Debt / EBITDA | 1.21 | 0.51 | 2.05 | 0.21 |
| Interest Coverage | 3.84 | 0.31 | 0.03 | 12.88 |
| Efficiency | ||||
| Inventory Turnover | 2.69 | 2.70 | 2.35 | 2.76 |
| Cash Conversion Cycle | 186.56 | 197.33 | 226.67 | 236.19 |